Effects of Cipepofol on Breathing Patterns, Respiratory Drive, and Inspiratory Effort in Mechanically Ventilated Patients

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2025 Mar 12

PMID 40070647

Authors

Rui Su

Linlin Zhang

Yu-Mei Wang

Ming-Yue Miao

Shuya Wang

Yong Cao

Jian-Xin Zhou

Affiliations

Soon will be listed here.

Abstract

Background: Cipepofol is a highly selective gamma-aminobutyric acid A receptor potentiator. As a new sedative drug, detailed studies on its respiratory effects are further needed. The present study aims to investigate the effects of cipepofol on breathing patterns, respiratory drive, and inspiratory effort in mechanically ventilated patients.

Methods: In this one-arm physiological study, cipepofol was initiated at 0.3 mg/kg/h and increased by 0.1 mg/kg/h every 30 min until reaching 0.8 mg/kg/h. Discontinuation criteria were Richmond Agitation and Sedation Scale (RASS) score ≤ -4 or respiratory rate (RR) < 8 breaths/min or pulse oxygen saturation (SpO) < 90%. The primary outcomes were changes from baseline in respiratory variables [RR, tidal volume (VT), minute ventilation (V), airway occlusion pressure at 100 msec (P), pressure muscle index (PMI), expiratory occlusion pressure (P)] at 30 min after 0.3 mg/kg/h cipepofol infusion. The secondary outcomes included changes in respiratory variables, cardiorespiratory variables, and RASS scores at rates of cipepofol from 0.3 to 0.8 mg/kg/h.

Results: 20 patients were enrolled and all of them completed the cipepofol infusion rate at 0.3 mg/kg/h, achieving RASS score of -2 to +1. For the primary outcomes, there was a significant reduction in VT (390.9, [356.6-511.0] vs. 451.6 [393.5-565.9],  = 0.002), while changes in RR (16.7 ± 2.7 vs. 16.2 ± 3.4,  = 0.465) and V (7.2 ± 1.8 vs. 7.5 ± 1.9,  = 0.154) were not significant. The reductions in P ( = 0.020), PMI ( = 0.019), and P ( = 0.007) were significant. For secondary outcomes, as the infusion rate of cipepofol increased from 0.3 to 0.8 mg/kg/h, there was a further decrease in VT ( = 0.002) and an increase in RR ( < 0.001), while the change in V ( = 0.430) was not significant. RASS score ( < 0.001) was further decreased.

Conclusion: Cipepofol demonstrates the capability to achieve RASS score -2 to +1 in mechanically ventilated adult patients. The effect of cipepofol on breathing patterns was a decrease in VT, while changes in RR and V were insignificant. The effect on respiratory drive and inspiratory effort significantly reduced P, PMI, and P.

Clinical Trial Registration: ClinicalTrials.gov, identifier NCT06287138. https://clinicaltrials.gov/study/NCT06287138.

References

Qin L, Ren L, Wan S, Liu G, Luo X, Liu Z . Design, Synthesis, and Evaluation of Novel 2,6-Disubstituted Phenol Derivatives as General Anesthetics. J Med Chem. 2017; 60(9):3606-3617. DOI: 10.1021/acs.jmedchem.7b00254. View

Novaes M, Knobel E, Bork A, Pavao O, Nogueira-Martins L, Ferraz M . Stressors in ICU: perception of the patient, relatives and health care team. Intensive Care Med. 2000; 25(12):1421-6. DOI: 10.1007/s001340051091. View

De Jong A, Molinari N, de Lattre S, Gniadek C, Carr J, Conseil M . Decreasing severe pain and serious adverse events while moving intensive care unit patients: a prospective interventional study (the NURSE-DO project). Crit Care. 2013; 17(2):R74. PMC: 3672726. DOI: 10.1186/cc12683. View

Cavaliere F, Antonelli M, Arcangeli A, Conti G, Costa R, Pennisi M . A low-dose remifentanil infusion is well tolerated for sedation in mechanically ventilated, critically-ill patients. Can J Anaesth. 2002; 49(10):1088-94. DOI: 10.1007/BF03017909. View

Prielipp R, Coursin D, Wood K, Murray M . Complications associated with sedative and neuromuscular blocking drugs in critically ill patients. Crit Care Clin. 1995; 11(4):983-1003. View

Li X, Yang D, Li Q, Wang H, Wang M, Yan P . Safety, Pharmacokinetics, and Pharmacodynamics of a Single Bolus of the γ-aminobutyric Acid (GABA) Receptor Potentiator HSK3486 in Healthy Chinese Elderly and Non-elderly. Front Pharmacol. 2021; 12:735700. PMC: 8430033. DOI: 10.3389/fphar.2021.735700. View

Goodman N, Black A . Inter-relations of the volume and timing components of ventilation during carbon dioxide rebreathing in awake and anaesthetized subjects. Br J Anaesth. 1987; 59(12):1504-13. DOI: 10.1093/bja/59.12.1504. View

Vincent J, Shehabi Y, Walsh T, Pandharipande P, Ball J, Spronk P . Comfort and patient-centred care without excessive sedation: the eCASH concept. Intensive Care Med. 2016; 42(6):962-71. PMC: 4846689. DOI: 10.1007/s00134-016-4297-4. View

Hagiwara A, Matsuura N, Ichinohe T . Comparison of Changes in Respiratory Dynamics Immediately After the Start of Propofol Sedation With or Without Midazolam. J Oral Maxillofac Surg. 2017; 76(1):52-59. DOI: 10.1016/j.joms.2017.05.038. View

10.

Goodman N, Black A, Carter J . Some ventilatory effects of propofol as sole anaesthetic agent. Br J Anaesth. 1987; 59(12):1497-503. DOI: 10.1093/bja/59.12.1497. View

11.

Puntillo K, Arai S, Cohen N, Gropper M, Neuhaus J, Paul S . Symptoms experienced by intensive care unit patients at high risk of dying. Crit Care Med. 2010; 38(11):2155-60. PMC: 3377582. DOI: 10.1097/CCM.0b013e3181f267ee. View

12.

Goligher E, Brochard L, Reid W, Fan E, Saarela O, Slutsky A . Diaphragmatic myotrauma: a mediator of prolonged ventilation and poor patient outcomes in acute respiratory failure. Lancet Respir Med. 2018; 7(1):90-98. DOI: 10.1016/S2213-2600(18)30366-7. View

13.

Kyogoku M, Shimatani T, Hotz J, Newth C, Bellani G, Takeuchi M . Direction and Magnitude of Change in Plateau From Peak Pressure During Inspiratory Holds Can Identify the Degree of Spontaneous Effort and Elastic Workload in Ventilated Patients. Crit Care Med. 2020; 49(3):517-526. PMC: 8176786. DOI: 10.1097/CCM.0000000000004746. View

14.

Goligher E, Fan E, Herridge M, Murray A, Vorona S, Brace D . Evolution of Diaphragm Thickness during Mechanical Ventilation. Impact of Inspiratory Effort. Am J Respir Crit Care Med. 2015; 192(9):1080-8. DOI: 10.1164/rccm.201503-0620OC. View

15.

Smith G, Prytherch D, Schmidt P, Featherstone P, Higgins B . A review, and performance evaluation, of single-parameter "track and trigger" systems. Resuscitation. 2008; 79(1):11-21. DOI: 10.1016/j.resuscitation.2008.05.004. View

16.

Spinelli E, Pesenti A, Slobod D, Fornari C, Fumagalli R, Grasselli G . Clinical risk factors for increased respiratory drive in intubated hypoxemic patients. Crit Care. 2023; 27(1):138. PMC: 10088111. DOI: 10.1186/s13054-023-04402-z. View

17.

Liu L, Wu A, Yang Y, Liu S, Huang Y, Xie J . Effects of Propofol on Respiratory Drive and Patient-ventilator Synchrony during Pressure Support Ventilation in Postoperative Patients: A Prospective Study. Chin Med J (Engl). 2017; 130(10):1155-1160. PMC: 5443020. DOI: 10.4103/0366-6999.205864. View

18.

Devlin J, Skrobik Y, Gelinas C, Needham D, Slooter A, Pandharipande P . Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018; 46(9):e825-e873. DOI: 10.1097/CCM.0000000000003299. View

19.

Payen J, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou J . Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology. 2007; 106(4):687-95. DOI: 10.1097/01.anes.0000264747.09017.da. View

20.

Aliverti A, Kostic P, Lo Mauro A, Andersson-Olerud M, Quaranta M, Pedotti A . Effects of propofol anaesthesia on thoraco-abdominal volume variations during spontaneous breathing and mechanical ventilation. Acta Anaesthesiol Scand. 2011; 55(5):588-96. DOI: 10.1111/j.1399-6576.2011.02413.x. View